Should You Invest in Provention Bio (PRVB)?
Tourlite Capital Management, an investment management company, released its fourth-quarter 2022 investor letter. A copy of the same can be downloaded here.
Provention Bio Inc. (PRVB)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Water Island Capital John Orrico | 0 | $0 | 0% | |
| 2. | GAMCO Investors Mario Gabelli | 0 | $0 | 0% | |
| 3. | 683 Capital Partners Ari Zweiman | 0 | $0 | 0% | |
| 4. | Pentwater Capital Management Matthew Halbower | 0 | $0 | 0% | |
| 5. | Palo Alto Investors William Leland Edwards | 0 | $0 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $6.49 | 5,201 | Officer | 70,000 | 2021-12-03 | Filing | |
| $6.66 | 3,750 | Officer, Director | 2,570,050 | 2021-11-30 | Filing | |
| $7.24 | 5,550 | Officer | 2,573,000 | 2021-11-24 | Filing | |
| $12.06 | 299 | Officer | 64,799 | 2020-09-02 | Filing | |
| $11.72 | 2,000 | Officer | 20,000 | 2020-09-02 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $24.32 | 2,190,549 | Large Shareholder | 15,567,497 | 2023-04-14 | Filing | |
| $10.04 | 25,985 | Officer | 1,573,000 | 2023-02-13 | Filing | |
| $10.11 | 50,000 | Officer | 1,573,000 | 2023-02-10 | Filing | |
| $10.00 | 4,500 | Officer | 0 | 2023-02-10 | Filing | |
| $10.04 | 25,835 | Officer, Director | 2,570,050 | 2023-02-13 | Filing |
Institutional Investors' Holdings
News See All
12 Best 52-Week High Stocks To Buy Now
The equity markets have been taking a beating this year as the Dow Jones Industrial Average (DJIA) Index, the S&P 500 Index, and the tech-heavy NASDAQ Composite Index have observed a year-to-date (YTD...
12 Best Biotech Stocks to Buy Under $10
The past two years have been challenging for the biotech sector, based on the market performance of biotech equities. Compared to larger stock market indexes, biotechnology indices underperformed.
11 Best Diabetes Stocks To Buy Now
The global diabetes market is segmented based on the type, drug class, and devices used to treat the condition.
Is PRVB A Good Stock To Buy Now?
Before we spend countless hours researching a company, we like to analyze what insiders, hedge funds and billionaire investors think of the stock first.
Hedge Funds Are Selling Provention Bio, Inc. (PRVB)
In this article we will check out the progression of hedge fund sentiment towards Provention Bio, Inc. (NASDAQ:PRVB) and determine whether it is a good investment right now.
Hedge Funds Have Never Been This Bullish On Provention Bio, Inc. (PRVB)
Hedge funds and large money managers usually invest with a focus on the long-term horizon and, therefore, short-lived dips or bumps on the charts, usually don't make them change their opinion towards ...